Skip to main content

Table 5 Estimated mean changes (95% confidence intervals) in scores from baseline to 3, 6, 9, and 12 months

From: Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study

Health-related quality of life domains

3 months

P

Size, direction

6 months

P

Size, direction

9 months

P

Size, direction

12 months

P

Size, direction

EORTC-QLQ-C30

Global health status

0.74

(− 4.48 to 5.96)

0.78

Trivial

6.61

(1.06–12.16)

0.02

Small improvement

7.66

(1.84–13.48)

0.01

Small improvement

6.39

(0.33–12.45)

0.04

Small improvement

Physical functioning

 − 2.39

(− 6.21 to 1.44)

0.21

Trivial

0.22

(− 3.85 to 4.28)

0.92

Trivial

 − 0.34

(− 4.63 to 3.95)

0.87

Trivial

1.57

(− 2.87 to 6.00)

0.48

Trivial

Role functioning

1.52

(− 4.68 to 7.72)

0.62

Trivial

2.94

(− 3.64 to 9.51)

0.37

Trivial

5.20

(− 1.74–12.14)

0.13

Trivial

4.40

(− 2.77–11.57)

0.22

Trivial

Emotional functioning

2.51

(− 1.53 to 6.55)

0.21

Trivial

3.76

(− 0.53 to 8.06)

0.08

Trivial

5.62

(1.11–10.12)

0.01

Small improvement

2.26

(− 2.43 to 6.95)

0.34

Trivial

Cognitive functioning

 − 3.21

(− 7.26 to 0.84)

0.11

Small deterioration

0.04

(− 4.28 to 4.36)

0.99

Trivial

 − 2.15

(− 6.68 to 2.39)

0.34

Trivial

 − 3.54

(− 8.26 to 1.18)

0.14

Small deterioration

Social functioning

 − 1.49

(− 6.63 to 3.64)

0.56

Trivial

3.37

(− 2.09 to 8.83)

0.22

Small improvement

2.01

(− 3.71 to 7.74)

0.48

Trivial

5.18

(− 0.78–11.14)

0.08

Small improvement

Fatigue

0.88

(− 3.91 to 5.67)

0.71

Trivial

 − 4.13

(− 9.22 to 0.95)

0.11

Small improvement

 − 5.87

(− 11.24 to − 0.51)

0.03

Small improvement

 − 4.83

(− 10.37 to 0.72)

0.08

Small improvement

Nausea and vomiting

1.61

(− 2.15 to 5.36)

0.39

Trivial

 − 3.52

(− 7.47 to 0.44)

0.08

Small improvement

 − 3.87

(− 8.03 to 0.29)

0.06

Small improvement

 − 4.23

(− 8.53 to 0.06)

0.05

Small improvement

Pain

 − 2.06

(− 7.32 to 3.20)

0.43

Trivial

 − 7.42

(− 13.00 to − 1.84)

0.01

Small improvement

 − 8.10

(− 13.98 to − 2.22)

0.01

Small improvement

 − 4.68

(− 10.76 to 1.40)

0.12

Trivial

Dyspnea

4.22

(− 0.93 to 9.38)

0.10

Trivial

 − 0.41

(− 5.88 to 5.06)

0.88

Trivial

5.15

(− 0.62–10.91)

0.08

Small deterioration

2.61

(− 3.35 to 8.57)

0.38

Trivial

Insomnia

5.59

(− 1.02–12.21)

0.09

Small deterioration

0.35

(− 6.65 to 7.36)

0.92

Trivial

 − 0.74

(− 8.12 to 6.64)

0.84

Trivial

 − 3.77

(− 11.41 to 3.86)

0.32

Trivial

Appetite loss

 − 2.41

(− 9.17 to 4.34)

0.48

Trivial

 − 3.24

(− 10.41 to 3.94)

0.37

Trivial

 − 6.16

(− 13.68 to 1.36)

0.10

Trivial

 − 5.56

(− 13.34 to 2.22)

0.15

Trivial

Constipation

2.59

(− 2.25 to 7.43)

0.29

Trivial

 − 2.00

(− 7.13 to 3.12)

0.44

Trivial

 − 0.70

(− 6.13 to 4.74)

0.80

Trivial

0.24

(− 5.34 to 5.82)

0.93

Trivial

Diarrhea

4.00

(− 1.86 to 9.86)

0.17

Trivial

 − 4.33

(− 10.57 to 1.91)

0.17

Trivial

 − 5.01

(− 11.55 to 1.54)

0.13

Small deterioration

 − 2.62

(− 9.43 to 4.20)

0.44

Trivial

Financial difficulties

2.80

(− 0.97 to 6.58)

0.14

Trivial

0.27

(− 3.74 to 4.29)

0.89

Trivial

0.82

(− 3.38 to 5.03)

0.70

Trivial

0.92

(− 3.46 to 5.30)

0.67

Trivial

HADS

Anxiety

0.02

(− 0.68 to 0.73)

0.95

No clinical change

 − 0.08

(− 0.82 to 0.66)

0.83

No clinical change

 − 0.76

(− 1.54 to 0.02)

0.05

No clinical change

0.15

(− 0.66 to 0.96)

0.72

No clinical change

Depression

 − 0.27

(− 0.93 to 0.39)

0.41

No clinical change

 − 0.55

(− 1.25 to 0.15)

0.12

No clinical change

 − 0.65

(− 1.38 to 0.09)

0.08

No clinical change

 − 0.56

(− 1.32 to 0.21)

0.15

No clinical change

  1. N, number of patients; EORTC, European Organization for Research and Treatment of Cancer; HADS, Hospital Anxiety and Depression Scale; CI, confidence interval
  2. Health-related quality of life domains with both a statistically significant and a clinically relevant change from baseline are marked in bold. Estimates are adjusted for effects of age and sex and with a random intercept per individual